Trials / Completed
CompletedNCT04371198
Patient-Derived Organoids for Rectal Cancer
Feasibility of Establishing Patient-Derived Organoids for Rectal Cancer: A Biospecimen Collection Protocol
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the feasibility of establishing patient-derived organoids from pre-treatment rectal adenocarcinoma biopsies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Biopsy | Tissue biopsy |
Timeline
- Start date
- 2020-09-18
- Primary completion
- 2022-08-17
- Completion
- 2022-08-17
- First posted
- 2020-05-01
- Last updated
- 2023-08-28
- Results posted
- 2023-08-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04371198. Inclusion in this directory is not an endorsement.